he shareholders Sunstone LSV Fund II K / S and SEED Capital DK II K / S have transferred all
of the subscription rights they were entitled to in the Rights Issue, amounting to a total of 47,490,810
rights, corresponding to 18.37 percent of the Rights Issue. The subscription rights have been
transferred to a number of qualified investors who have agreed to subscribe for shares using the
subscription rights, corresponding to a subscription value of SEK 10.3 million in the Rights issue.
Acarix was establish in 2009 and is listed on Nasdaq First North Growth Market. Acarix's CADScor@System uses an advanced sensor placed on the skin above the heart to listen to the sounds of cardiac contraction movement and turbulent flow. It has been designed to be an all-in-on system in the sense that the heart signal will be recorded, processed, and displayed as a patient specific score, the CAD-score, on the device screen.